Small Hospitals
Market Cap
₹10,082 ₹10,082 Cr.
P/E
442.57
PEG
6.72
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

Base case is anchored on existing oncology centers delivering ~72% of growth through higher utilization, case-mix improvement, and brownfield expansion, with margins reaching 21.5% as fixed costs absorb volume.

Bull case requires faster-than-modeled utilization gains and successful commercialization of North Bangalore and Whitefield; bear case materializes if existing-center growth stalls below 12% or new centers face significant delays.

Key downside triggers are ex-Milann revenue growth below 12% for two consecutive quarters, or delayed operationalization of Cuttack and Bangalore projects.

Key Ratios

Debt to Equity
Debt to Equity
0.68
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
6.56 %
Institutions
Institutions
21.94 %
Market cap
Market cap
10,082 Cr
No. of Shareholders
No. of Shareholders
48,905
OPM (%)
OPM (%)
18.28 %
PE
PE
442
Prom Holding
Prom Holding
64.21 %
ROCE (%)
ROCE (%)
8.50
ROE (%)
ROE (%)
1.03
Sales
Sales
2,627 Cr
  • Healthcare Global
  • Yatharth Hospital
  • Jupiter Life Line
  • TJI Hospitals
Last updated on 16 Sep 2026
  • HCG runs India's largest dedicated cancer-care hospital network across India and Africa. It provides surgical, medical and radiation oncology with diagnostics, genomics and fertility care that it is exiting.
  • Profit comes from mature centres. Newer Mumbai and Kolkata centres are ramping. Growth comes mainly from higher occupancy.
  • It runs a single-specialty tumour-board-led model. Per management, its radiotherapy base is 3x the closest competitor.
  • It is expanding beds at existing centres. It is ramping its new North Bangalore hospital. Management guides ₹600-700Cr capex over 2-3 years.
  • It was de-geared by a ₹425Cr rights issue. Net debt to EBITDA is 1.4x against a 2.5x ceiling. This leaves room to fund expansion.
  • It is in mid-ramp on capacity and margin expansion. Management guides ~15% medium-term revenue growth and 21-22% EBITDA margin in two years.
  • About 30% of revenue comes from government payors. Price caps on government schemes cost about 1.5% of the top line.
  • Fertility business sale by Dec 2026
    it brings ₹28.2Cr upfront plus ₹9.4Cr deferred. It removes the fertility drag.
  • ₹600-700Cr capex plan 2-3 years from Dec 2025
    it targets 1,000 new beds with 700 brownfield and 300 greenfield. ₹300Cr is maintenance.
  • Cuttack hospital expansion next 24 months
    75 new cancer beds come online.
  • New North Bangalore hospital 2-3 years from FY26
    losses are guided to reduce as occupancy ramps.
  • Kenya cancer operation expansion No timeline for guarantee release
    it adds 10% for ₹7Cr plus a USD1.8Mn loan guarantee. Revenue grew 71% in FY26.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
513
52W Range
High
800
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Hospitals

Segment Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Payment Mode

Brand Wise Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Operational Beds (.)
    • Advertisement Spend as a % of Total Sales (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Healthcare Global Enterprises Ltd. Business

    HealthCare Global Enterprises Ltd (HCG) is India's largest provider of cancer care with a network of comprehensive cancer centers. They also own fertility centers under the brand 'Milann', leading in specialist tertiary healthcare.

    Healthcare Global major competitors are Yatharth Hospital, Jupiter Life Line, Kovai Medical Center, RainbowChildrenS Med, Artemis MedicareServ, Indraprastha Medical, Dr Agarwals Eye Hosp.
    Market Cap of Healthcare Global is ₹10,353 Crs.
    While the median market cap of its peers are ₹6,788 Crs.

    Healthcare Global seems to be less financially stable compared to its competitors.
    Altman Z score of Healthcare Global is 3.67 and is ranked 8 out of its 8 competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb May Aug May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Feb May Aug May Aug Nov Dec Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar May Jun Aug Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Feb May Aug Mar Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material